203 related articles for article (PubMed ID: 32969723)
1. Iron metabolism in
Zhang Y; Pan X; Wang L; Chen L
J Drug Target; 2021 Mar; 29(3):249-258. PubMed ID: 32969723
[No Abstract] [Full Text] [Related]
2. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
[TBL] [Abstract][Full Text] [Related]
3. The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa.
Oglesby-Sherrouse AG; Djapgne L; Nguyen AT; Vasil AI; Vasil ML
Pathog Dis; 2014 Apr; 70(3):307-20. PubMed ID: 24436170
[TBL] [Abstract][Full Text] [Related]
4. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
[TBL] [Abstract][Full Text] [Related]
5. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Smith S; Waters V; Jahnke N; Ratjen F
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
[TBL] [Abstract][Full Text] [Related]
6. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
[TBL] [Abstract][Full Text] [Related]
7. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
[TBL] [Abstract][Full Text] [Related]
8. Plant-derived Compounds as Potential Source of Novel Anti-Biofilm Agents Against Pseudomonas aeruginosa.
Chung PY
Curr Drug Targets; 2017; 18(4):414-420. PubMed ID: 27758704
[TBL] [Abstract][Full Text] [Related]
9. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
10. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.
Jakobsen TH; Bjarnsholt T; Jensen PØ; Givskov M; Høiby N
Future Microbiol; 2013 Jul; 8(7):901-21. PubMed ID: 23841636
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
12. The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms.
Germoni LA; Bremer PJ; Lamont IL
J Appl Microbiol; 2016 Jul; 121(1):126-35. PubMed ID: 27061817
[TBL] [Abstract][Full Text] [Related]
13. A Survival Strategy for Pseudomonas aeruginosa That Uses Exopolysaccharides To Sequester and Store Iron To Stimulate Psl-Dependent Biofilm Formation.
Yu S; Wei Q; Zhao T; Guo Y; Ma LZ
Appl Environ Microbiol; 2016 Nov; 82(21):6403-6413. PubMed ID: 27565622
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of pomegranate and rosemary extracts in combination with antibiotics against antibiotic resistance and biofilm formation of Pseudomonas aeruginosa.
Abu El-Wafa WM; Ahmed RH; Ramadan MA
Braz J Microbiol; 2020 Sep; 51(3):1079-1092. PubMed ID: 32394240
[TBL] [Abstract][Full Text] [Related]
15. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
Jensen PØ; Briales A; Brochmann RP; Wang H; Kragh KN; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Ciofu O
Pathog Dis; 2014 Apr; 70(3):440-3. PubMed ID: 24376174
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies.
Pang Z; Raudonis R; Glick BR; Lin TJ; Cheng Z
Biotechnol Adv; 2019; 37(1):177-192. PubMed ID: 30500353
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Artesunate against
Bao L; Guo J; Feng L; Zhou X; Lu Q
Biomed Res Int; 2019; 2019():4810217. PubMed ID: 31815139
[No Abstract] [Full Text] [Related]
19. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
[No Abstract] [Full Text] [Related]
20. Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions.
O'May CY; Sanderson K; Roddam LF; Kirov SM; Reid DW
J Med Microbiol; 2009 Jun; 58(Pt 6):765-773. PubMed ID: 19429753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
